Investing to Fight Toilet and Elevator Superbugs

A big thank-you to our friends at FierceHealthcare for an incredible story about how a recent study indicated that hospital elevator buttons might have a higher prevalence of bacteria colonization than toilets.

Yes, you read that correctly. Hospital elevator buttons showed a 61% prevalence of bacteria colonization, while only 43% of toilet surfaces were colonized in a study covering three teaching hospitals in Toronto, Ontario.

Of course, this has some unfortunate implications for potential cross-contamination in hospitals, although keep in mind that this study only covered three hospitals during a brief period of time. Still, though, this is another data point in a bigger push for hospitals and other businesses to focus on sanitation and help prevent infections from a variety of bacteria including Methicillin-resistant Staphylococcusaureus (also known as MRSA).

Fortunately, new drugs are coming on the market to help fight back against these and other bacteria behind acute bacterial skin and skin structure infections (known as ABSSSI for short, and MRSA can be one of the causes). Durata Therapeutics'  (NASDAQ: DRTX  ) Dalvance and Cubist Pharmaceuticals'  (NASDAQ: CBST.DL  ) Sivextro are two newly-approved drugs that can help lead the fight against ABSSSI. Neither is expected to be a blockbuster -- peak sales estimates hover around $400 million each -- but both were brought on the market under the new FDA QIDP (Qualified Infectious Disease Product) designation created to help convince pharma companies to invest more in antibiotics.

In the video below, from Where The Money Is, Motley Fool health care analysts Michael Douglass and David Williamson lay out the opportunity for Durata and Cubist in the ABSSSI space and whether either company has potential as an attractive investment in someone's stock portfolio.

Leaked: This coming blockbuster will make even Cubist and Durata jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 21, 2014, at 3:01 AM, mrsaresistance wrote:

    I know that I will sound like a total crackpot. But I have nothing to sell, no motive other than helping people. And I can't seem to get any news agency interested in this story.

    There is a CURE for MRSA in your kitchen cabinet. An all natural one, and I use it DAILY for infections of a viral, fungal and bacterial nature. I fight MRSA with it, as do hundreds who also know about it.

    It's GARLIC. And it WORKS. MRSA can never build a resistance and, unlike antibiotics, it doesn't linger in your system or create a stronger superbug. PLEASE find someone willing to report this information!! All these news stories of high school kids with problems and crushing live garlic could save them ALL!!!

    PLEASE!!! I have reached out to Pro football teams, and gotten no answer. I have reached out to media outlet after media outlet. TRY THIS YOURSELF!! It works. GOOGLE IT!

    Please read this blog about Garlic baths and MRSA you can also check our page There are ways to beat MRSA fast, natural and without fail. We are NOT selling anything. You can grow your own garlic for this cure. It is SCIENTIFICALLY PROVEN and one attempt will remove any doubt for only pennies. I am a sufferer myself and I use garlic constantly to fight infection.

    All these articles to scare people about MRSA and no reporters have looked to see what long term sufferers are doing to fight it, and THIS is what we are using!!

    Thanks for reading,

    Christopher Johnston

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3034934, ~/Articles/ArticleHandler.aspx, 9/3/2015 11:14:34 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Michael Douglass

As the Motley Fool's Health Care Editor/Analyst, I focus on all things health care -- although my greatest interest is in the megatrends reshaping the American health care system, including the Affordable Care Act, Accountable Care Organizations, a shifting regulatory landscape, and the new drug discoveries fundamentally changing disease management and treatment.

Today's Market

updated Moments ago Sponsored by:
DOW 16,540.85 189.47 1.16%
S&P 500 1,972.10 23.24 1.19%
NASD 4,794.44 44.46 0.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
CBST.DL $0.00 Down +0.00 +0.00%
Cubist Pharmaceuti… CAPS Rating: ****
DRTX $0.00 Down +0.00 +0.00%
Durata Therapeutic… CAPS Rating: **